1. Home
  2. CTKB vs THQ Comparison

CTKB vs THQ Comparison

Compare CTKB & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • THQ
  • Stock Information
  • Founded
  • CTKB 1990
  • THQ 2014
  • Country
  • CTKB United States
  • THQ United States
  • Employees
  • CTKB N/A
  • THQ N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • THQ Finance Companies
  • Sector
  • CTKB Health Care
  • THQ Finance
  • Exchange
  • CTKB Nasdaq
  • THQ Nasdaq
  • Market Cap
  • CTKB 718.8M
  • THQ 845.7M
  • IPO Year
  • CTKB 2021
  • THQ N/A
  • Fundamental
  • Price
  • CTKB $4.00
  • THQ $20.44
  • Analyst Decision
  • CTKB Buy
  • THQ
  • Analyst Count
  • CTKB 2
  • THQ 0
  • Target Price
  • CTKB $7.00
  • THQ N/A
  • AVG Volume (30 Days)
  • CTKB 957.9K
  • THQ 158.9K
  • Earning Date
  • CTKB 05-07-2025
  • THQ 01-01-0001
  • Dividend Yield
  • CTKB N/A
  • THQ 7.53%
  • EPS Growth
  • CTKB N/A
  • THQ N/A
  • EPS
  • CTKB N/A
  • THQ N/A
  • Revenue
  • CTKB $200,453,000.00
  • THQ N/A
  • Revenue This Year
  • CTKB $6.66
  • THQ N/A
  • Revenue Next Year
  • CTKB $9.54
  • THQ N/A
  • P/E Ratio
  • CTKB N/A
  • THQ N/A
  • Revenue Growth
  • CTKB 3.85
  • THQ N/A
  • 52 Week Low
  • CTKB $3.98
  • THQ $15.29
  • 52 Week High
  • CTKB $7.63
  • THQ $20.38
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 32.03
  • THQ 46.91
  • Support Level
  • CTKB $4.03
  • THQ $20.20
  • Resistance Level
  • CTKB $4.41
  • THQ $21.07
  • Average True Range (ATR)
  • CTKB 0.18
  • THQ 0.33
  • MACD
  • CTKB 0.03
  • THQ -0.05
  • Stochastic Oscillator
  • CTKB 4.21
  • THQ 31.87

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest

abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies.

Share on Social Networks: